DECA(Delisted)
Denali CapitalยทNASDAQ
--
--(--)
DECA Profile
Semnur Pharmaceuticals, Inc.
A Special Purpose Acquisition Company
437 Madison Avenue, 27th Floor, New York, New York 10022
--
Semnur Pharmaceuticals, Inc., incorporated in the Cayman Islands on January 5, 2022, changed to Delaware on 20250923. The purpose of the company is to carry out a merger, share capital transaction, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
